ask="44.04"
ask_size="500"
average_daily_volume="1113160"
bid="41.62"
bid_size="400"
book_value="4.05"
change="-0.42"
change_from_200_day_moving_average="-5.48"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-13.53"
change_From_52_week_low="10.37"
change_in_percent="-1.00%"
close="41.62"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.44"
eps_estimate_next_year="-1.79"
ex_dividend_date="N/A"
float_shares="85807000"
high="42.15"
high_52_weeks="55.15"
last_trade_date="1/19/2017"
last_trade_price="41.62"
last_trade_size="150"
last_trade_time="4:00pm"
low="40.36"
low_52_weeks="31.25"
market_capitalization="3.62B"
moving_average_200_day="47.10"
moving_average_50_day="41.69"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="41.93"
pe_ratio="N/A"
peg_ratio="0.69"
percent_change_from_200_day_moving_average="-11.64%"
percent_change_from_50_day_moving_average="-0.16%"
percent_change_from_52_week_high="-24.53%"
percent_change_from_52_week_low="+33.18%"
previous_close="42.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.39"
price_per_sales="243.47"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="1218137"
weeks_range_52="31.25 - 55.15"
